MP Doherty critical of Federal Toxic Drug Strategy

Health leaders have described the latest figures as a sign of “cautious optimism,” pointing to expanded access to naloxone, changes in the illegal drug supply, and broader public health interventions as contributing factors. However, they are also warning that progress is fragile and uneven across the country, with some regions continuing to experience high rates of overdose and harm.

At a national level, the federal government has emphasized that the toxic drug crisis remains one of the most serious public health challenges facing Canada. The crisis has claimed tens of thousands of lives over the past decade and has had a measurable impact on communities, families, and even national life expectancy trends.

Federal Health Minister Marjorie Michel acknowledged the complexity of the situation in remarks tied to the new data, emphasizing that no single policy solution will be sufficient. She has argued that a “one-size-fits-all” approach is ineffective in addressing a crisis driven by a wide range of factors, including mental health, poverty, housing instability, and an increasingly toxic and unpredictable drug supply.

Michel has also highlighted the importance of a coordinated national response that includes harm reduction, treatment programs, and prevention initiatives. Federal investments have supported hundreds of organizations delivering services across the country, including culturally specific programs and community-based interventions.

But while the federal government points to declining mortality rates as evidence that its approach is working, critics argue that the numbers alone do not tell the full story.

Cariboo–Prince George MP Todd Doherty is among those calling for a fundamental shift in focus. In response to the federal announcement, Doherty questioned whether government programs are achieving meaningful results on the ground.

“After 10 years of crisis, Canadians deserve more than announcements. They deserve results,” Doherty said in a recent statement, adding that communities across northern British Columbia continue to struggle with the effects of drug toxicity.

Doherty has been particularly critical of what he describes as a lack of transparency around recovery outcomes. He argues that while the government frequently reports spending levels and program expansions, it does not clearly measure how many people are successfully entering long-term recovery.

In Prince George alone, dozens of lives were lost to toxic drugs in 2025, underscoring the ongoing toll in smaller and northern communities.

For the Conservative opposition, the path forward centres on three main pillars: prevention, treatment, and enforcement. Doherty has called for expanded education efforts aimed at young people, improved access to addiction treatment services, and stricter penalties for those involved in trafficking substances such as fentanyl.

The issue of enforcement has become particularly polarizing, as policymakers debate the balance between public health approaches and criminal justice responses. The federal government has taken steps to disrupt the illegal drug trade through border measures, chemical controls, and enhanced surveillance, while also funding harm reduction initiatives designed to prevent overdose deaths.

Public health experts, however, have warned that enforcement alone cannot resolve a crisis rooted in a toxic illicit supply. Fentanyl and its analogues continue to drive the majority of overdose deaths, often appearing in combination with other substances, making the drug environment more dangerous and unpredictable.

The broader data also highlights how the crisis has evolved over time. Since national tracking began in 2016, Canada has recorded more than 56,000 apparent opioid toxicity deaths, with the majority occurring in recent years. The rise of synthetic opioids, particularly fentanyl, has been a key factor behind the surge in fatalities.

Although 2025 marked a turning point with declining deaths, the numbers remain well above pre-pandemic levels, and emergency response calls for overdoses have continued to rise in some areas. This suggests that while fewer people are dying, many are still experiencing life-threatening drug-related events.

Health officials say that reality underscores the need for sustained, coordinated action across all levels of government — and across the continuum of care, from prevention and harm reduction to treatment and recovery.

“The progress we are seeing today reminds us that change is possible,” Health Canada said in a statement accompanying the data release. “But it also reminds us that there is more work to do.”

For communities on the front lines, that work remains urgent. Families continue to lose loved ones, emergency responders remain under strain, and service providers face ongoing challenges meeting demand.

As Canada enters another year in its fight against the toxic drug crisis, the debate over what constitutes success — and how to measure it — is likely to intensify. While declining death rates offer a measure of hope, both government officials and critics agree on one point: the crisis is far from over.

by Nick Dube

MP Doherty critical of Federal Toxic Drug Strategy

What's Trending